LCTX insider transaction filings
Lineage Cell Therapeutics, Inc. — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-02. Screen LCTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Amin Dipti — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Jayasuriya Anula — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Russell Angus C. — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Mulroy Michael H. — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | ANDREWS DEBORAH J — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Bradsher Neal C — Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Culley Brian M — President and CEO, Director | Purchase (P): 15,000 @ $1.62 | EDGAR |
| 2026-03-06 | 4 | Howe Jill Ann — Chief Financial Officer | Grant/award (A): 1,050,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 3,250,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Samuel George A. III — General Counsel and Secretary | Option exercise (M): 6,075 · Tax withholding (F): 2,502 @ $1.80 · Option exercise (M): 6,075 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Culley Brian M — President and CEO, Director | Option exercise (M): 31,250 · Tax withholding (F): 12,869 @ $1.80 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 1,735 · Tax withholding (F): 65 @ $1.68 | EDGAR |
| 2025-12-19 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 8,925 · Tax withholding (F): 334 @ $1.68 | EDGAR |
| 2025-07-03 | 4 | Bradsher Neal C — Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Amin Dipti — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Jayasuriya Anula — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Russell Angus C. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Mulroy Michael H. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | ANDREWS DEBORAH J — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Howe Jill Ann — Chief Financial Officer | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 2,300,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Samuel George A. III — General Counsel | Option exercise (M): 6,076 · Tax withholding (F): 2,440 @ $0.65 · Option exercise (M): 6,076 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Culley Brian M — President and CEO, Director | Option exercise (M): 31,249 · Tax withholding (F): 12,547 @ $0.65 · Option exercise (M): 31,249 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | BROADWOOD PARTNERS, L.P. — Director, 10% owner BROADWOOD CAPITAL INC — 10% owner BRADSHER NEAL C — Director, 10% owner | Purchase (P): 7,894,737 @ $0.76 · Purchase (P): 0 @ $0 · Purchase (P): 7,894,737 (derivative) @ $0 · Purchase (P): 0 (derivative) @ $0 | EDGAR |
Recent 8-K events — Lineage Cell Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-26 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LCTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →